14 mars 2012
Screen proteomic identifie des changement au niveau du Complement C3 dans l'autisme,
potentiellement valide comme screen, diagnosis et prognosis.
Voir : http://www.nature.com/tp/journal/v2/n3/pdf/tp201219a.pdf
Lorene Amet D.Phil. (Oxon) M.Ed. (Autism)
Autism Treatment Trust is a 'Not for Profit' organisation, Scottish Charity
Number SC033523, Company Number SC236901.
The information contained in this e-mail is strictly confidential and for
the use of the addressee only; it may also be legally privileged and/or
price sensitive. Notice is hereby given that any disclosure, use or copying
of the information by anyone other than the intended recipient is prohibited
and may be illegal. If you have received this message in error, please
notify us immediately by return e-mail or ring +44 (131) 558 7444 and ask
for the sender.
The Autism Treatment Trust has taken every reasonable precaution to ensure
that any attachment to this e-mail has been swept for viruses. However, we
cannot accept liability for any damage sustained as a result of software
viruses and would advise that you carry out your own virus checks before
opening any attachment.
Published by Chronimed